ロード中...
Galantamine — a Novel Cholinergic Drug with a Unique Dual Mode of Action for the Treatment of Patients with Alzheimer's Disease
Galantamine hydrobromide is a tertiary alkaloid drug that has been developed and approved in a number of countries including the USA and several countries in Europe as a treatment for mild‐to‐moderate Alzheimer's disease (AD). Galantamine has a unique, dual mode of action. It is a reversible, c...
保存先:
| 出版年: | CNS Drug Rev |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Blackwell Publishing Ltd
2006
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6741688/ https://ncbi.nlm.nih.gov/pubmed/12177686 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1527-3458.2002.tb00221.x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|